Niagen Bioscience, Inc. NAGE
Set alert
2.39 USD +0.05 +2.36%
As of Nov 2, 11:50 AM ET
2.35 Day range 2.40
2.32 52-week range 7.95
- YTD
- -62.50%
- 1 year
- -68.37%
- Open
- 2.36
- Prev close
- 2.33
- Mkt cap
- 188.72M
- Vol
- 112.23K
- Avg vol
- 534.38K
- EPS
- 0.19
- P/E
- 12.55
- Div yield
- 0.00%
More statistics
- Low
- 2.35
- High
- 2.40
- Forward P/E
- 0.00
- Beta
- 2.08
- Short ratio
- 3.35
- Inst. own
- 33.09%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2025
- 50-d avg
- 10.88
- 200-d avg
- 7.00
- 1y target
- 14.90
5D chart
Signals (50)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 9:30 AM | 2 hours ago |
| SMA: Bullish | Nov 2, 9:30 AM | 2 hours ago |
| MACD: Buy Signal | Nov 2, 9:30 AM | 2 hours ago |
| MACD: Sell Signal | Oct 30, 3:55 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 3:00 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:45 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:45 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:35 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:30 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:25 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 11:50 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:10 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 11:05 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:55 PM | 3 days ago |
| RSI: Oversold | Oct 29, 3:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:25 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:10 PM | 3 days ago |
| RSI: Oversold | Oct 29, 2:50 PM | 3 days ago |
| RSI: Oversold | Oct 29, 2:05 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:40 PM | 3 days ago |
| RSI: Oversold | Oct 29, 1:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 1:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:35 AM | 4 days ago |
| MACD: Buy Signal | Oct 29, 11:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 10:15 AM | 4 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:55 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:15 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:00 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:00 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 1:30 PM | 4 days ago |
| RSI: Overbought | Oct 28, 12:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 11:50 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 11:15 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 11:00 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:55 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 10:30 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:00 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 10:00 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:50 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:05 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:35 PM | 5 days ago |
| RSI: Overbought | Oct 27, 2:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:05 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:05 PM | 5 days ago |
| RSI: Overbought | Oct 27, 1:25 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:20 PM | 5 days ago |
| RSI: Overbought | Oct 27, 10:50 AM | 6 days ago |
Financial health
Altman Z-Score
5.19 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 4
- P/E 3
- P/B 2
Valuation
P/E 28.9×
FY 2016 5y median -7.0× FY 2025
P/S 3.9×
FY 2016 5y median 3.7× FY 2025
P/B 6.6×
FY 2016 5y median 6.6× FY 2025
P/FCF 38.3×
FY 2016 5y median 14.5× FY 2025
EV/EBITDA 22.5×
FY 2016 5y median -6.8× FY 2025
EV/Sales 3.4×
FY 2016 5y median 3.4× FY 2025
FCF Yield 2.6%
FY 2016 5y median 2.6% FY 2025
Profitability
Gross Margin 64.3%
FY 2016 5y median 61.5% FY 2025
Operating Margin 11.0%
FY 2016 5y median -6.7% FY 2025
Net Margin 13.4%
FY 2016 5y median -5.9% FY 2025
ROE 22.7%
FY 2016 5y median -17.4% FY 2025
ROIC 15.6%
FY 2016 5y median -16.0% FY 2025
ROA 16.3%
FY 2016 5y median -9.0% FY 2025
Growth (YoY)
Revenue 29.9%
FY 2016 FY 2025
Operating Income 85.0%
FY 2016 FY 2025
EPS (diluted) 81.8%
FY 2016 FY 2025
Free Cash Flow 10.0%
FY 2016 FY 2025
Financial Health
Current Ratio 4.9×
FY 2016 5y median 2.8× FY 2025
Quick Ratio 3.8×
FY 2016 5y median 2.0× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -3.2×
FY 2016 5y median 0.9× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31